Qianhai Health Holdings (HKSE:00911) Moat Score: 0/10 (As of Aug. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:00911 Qianhai Health Holdings Ltd HKSE:00911
39 GF Score
Price HK$0.60
GF Value HK$0.22
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Qianhai Health Holdings Moat Score?

Qianhai Health Holdings has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Qianhai Health Holdings has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Qianhai Health Holdings might have No Moat - No discernible moat.

Qianhai Health Holdings  (HKSE:00911) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Qianhai Health Holdings Moat Score Related Terms

HKSE:00911
39GF Score
Qianhai Health Holdings Ltd HKSE:00911
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Qianhai Health Holdings (HKSE:00911) Overvalued in 2026?

Based on GuruFocus' analysis, Qianhai Health Holdings stock appears to be overvalued. The current stock price of HK$0.60 is trading 172.7% above its estimated GF Value™ of HK$0.22. GuruFocus considers Qianhai Health Holdings to be Significantly Overvalued.

Key valuation signals for HKSE:00911:

  • Moat Score: 0
  • GF Value™: HK$0.22 vs. price of HK$0.60 (172.7% above fair value)
  • GF Score™: 39/100 with 2 warning signs

No single metric tells the full story. See the HKSE:00911 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Qianhai Health Holdings Business Description

Address 177-183 Wing Lok Street, Room 301-3, 3rd Floor, Wing Tuck Commercial Centre, Sheung Wan, Hong Kong, HKG
Qianhai Health Holdings Ltd principally engaged in the sale of health products and electronic component products. It includes Chinese herbal medicines, skin-care and other healthcare products, and the sale of information technology components. The operating segments of the group are Healthcare products and Electronic component products. Healthcare products include the sale of healthcare products, including Chinese herbal medicines, skincare, and other healthcare products. Electronic component products include the sale of information technology components products including central processing units and semiconductors. The group's revenue is all derived from Hong Kong.
39GF Score

Get the complete analysis for HKSE:00911

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.60
Price
HK$0.22
GF Value